The Clinical Usefulness of Combination Assay of MG7 - Ag and CEA in Gastric Cancer / 대한면역학회지
Korean Journal of Immunology
;
: 81-84, 1998.
Article
in Korean
| WPRIM
| ID: wpr-56517
ABSTRACT
Recently new tumor marker, MG7-Ag has been introduced for screening of gastric cancer. In this study MG7-Ag and CEA in sera of 50 normal healthy Koreans and 48 patients with gastric cancer group were determined to elucidate the clinical usefulness for gastric cancer screening. Commercial Enzyme Immuno Assay kits were used for analysis of above two markers. Sensitivity of MG7-Ag and CEA in patient group were found to be 43.8% and 41.7%, respectively. When the two markers were used combind, sensitivity increased to 62.5%. The concentration of MG7-Ag in patients (9.2+11.7 U/mL) was five times higher than normal control group (1.81+1.63 U/mL). CEA was 31.2+46.5 ng/mL in patients and 2.24+0.98 ng/mL (MeanSD) in normal control group. From this results, combination assay of MG7-Ag and CEA is more useful in clinical laboratories for screening gastric cancer than using one marker.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Stomach Neoplasms
/
Mass Screening
Type of study:
Screening study
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Immunology
Year:
1998
Type:
Article
Similar
MEDLINE
...
LILACS
LIS